Assembly Company Overview, Contact Details & Competitors

Q: What is Assembly's official website and social media links?

Assembly's official website is assemblygroup.com. Assembly has social profiles on LinkedIn.

Q: How many employees does Assembly have currently?

Assembly has approximately 36 employees.

Q: What technology does Assembly use?

Assembly's tech stack includes X-Content-Type-Options, HSTS, Squarespace Commerce, Cart Functionality, Squarespace.

Insights

Gathering insights about Assembly…

Similar companies to Assembly

Assembly Tech Stack

Assembly uses 8 technology products and services including Open Graph, Squarespace Commerce, JSON-LD, and more. Explore Assembly's tech stack below.

Open Graph
Content Management System
Squarespace Commerce
E-commerce
JSON-LD
Javascript Frameworks
Choices
Javascript Libraries
Lightbox
Javascript Libraries
HSTS
Security
X-Content-Type-Options
Web & Portal Technology
Adobe Fonts
Web Fonts

Media & News

Head to Head Comparison: Parnell Pharmaceuticals (OTCMKTS:PARNF) and Assembly Biosciences (NASDAQ:ASMB)
Parnell Pharmaceuticals (OTCMKTS:PARNF - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk, earnings, dividends, valuation, profitability and analyst recommendations. Valuation and Earnings This table compares Parnell Pharmaceuticals
Feb 08, 2026 | www.defenseworld.net
Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL)
Sol-Gel Technologies (NASDAQ: SLGL - Get Free Report) and Assembly Biosciences (NASDAQ: ASMB - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Valuation and Earnings This table compares Sol-Gel
Jan 20, 2026 | www.defenseworld.net
Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes
FOSTER CITY, Calif. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) and Assembly Biosciences, Inc. (Nasdaq: ASMB), today announced Gilead has exercised its combined option to exclusively license Assembly Bio's herpes simplex virus (HSV) helicase-primase inhibitor programs, including long-acting investigational candidates ABI-1179 and ABI-5366 for recurrent genital herpes. These represent the first programs Gilead will advance under the ongoing Assembly Bio R.
Dec 22, 2025 | www.businesswire.com
Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript
Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript
Dec 08, 2025 | seekingalpha.com
Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes
– 98% reduction in HSV-2 shedding rate, >99% reduction in high viral load shedding rate and 91% reduction in virologically confirmed genital lesion rate observed in 50 mg weekly oral dose of ABI-1179, exceeding expectations for the study –
Dec 08, 2025 | www.globenewswire.com
Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of “Moderate Buy” by Analysts
Shares of Assembly Biosciences, Inc. (NASDAQ: ASMB - Get Free Report) have received an average rating of "Moderate Buy" from the eight brokerages that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and six have issued a buy recommendation on
Dec 08, 2025 | www.defenseworld.net
Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives $41.25 Consensus PT from Brokerages
Assembly Biosciences, Inc. (NASDAQ: ASMB - Get Free Report) has received an average rating of "Moderate Buy" from the seven brokerages that are currently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and five have given a buy rating to the
Nov 16, 2025 | www.defenseworld.net

Assembly's Email Address Formats

Assembly uses at least 1 format(s):

Assembly Email Formats	Example	Percentage
First@assemblygroup.com	John@assemblygroup.com	50%
First@assemblygroup.com	John@assemblygroup.com	50%

Frequently Asked Questions

Where is Assembly's headquarters located?

Assembly's main headquarters is located at 3101 Bee Cave Road #305 Austin, Texas United States. The company has employees across 5 continents, including North AmericaAsiaAfrica.

What is Assembly's stock symbol?

Assembly is a publicly traded company; the company's stock symbol is ASMB.

What is Assembly's official website and social media links?

Assembly's official website is assemblygroup.com and has social profiles on LinkedIn.

What is Assembly's NAICS code?

Assembly's NAICS code is 5613 - Employment Services.

How many employees does Assembly have currently?

As of February 2026, Assembly has approximately 36 employees across 5 continents, including North AmericaAsiaAfrica. Key team members include Vice President Of Operations: E. E.Founding Partner: C. C.Partner: M. G. W.. Explore Assembly's employee directory with LeadIQ.

What industry does Assembly belong to?

Assembly operates in the Staffing and Recruiting industry.

What technology does Assembly use?

Assembly's tech stack includes Open GraphSquarespace CommerceJSON-LDChoicesLightboxHSTSX-Content-Type-OptionsAdobe Fonts.

What is Assembly's email format?

Assembly's email format typically follows the pattern of First@assemblygroup.com. Find more Assembly email formats with LeadIQ.

When was Assembly founded?

Assembly was founded in 2019.

Insights

Similar companies to Assembly

Publicis Groupe

WPP

Accenture Interactive

Deloitte Digital

dentsu Japan

R/GA

Interpublic Group (IPG)

Assembly Tech Stack

Media & News

Head to Head Comparison: Parnell Pharmaceuticals (OTCMKTS:PARNF) and Assembly Biosciences (NASDAQ:ASMB)

Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL)

Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

Assembly Biosciences, Inc. (ASMB) Discusses Positive Interim Results for ABI-1179 and ABI-5366 in Recurrent Genital Herpes Phase 1b Studies Transcript

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes

Assembly Biosciences, Inc. (NASDAQ:ASMB) Given Average Recommendation of “Moderate Buy” by Analysts

Assembly Biosciences, Inc. (NASDAQ:ASMB) Receives $41.25 Consensus PT from Brokerages

Assembly's Email Address Formats

Frequently Asked Questions

Where is Assembly's headquarters located?

What is Assembly's stock symbol?

What is Assembly's official website and social media links?

What is Assembly's NAICS code?

How many employees does Assembly have currently?

What industry does Assembly belong to?

What technology does Assembly use?

What is Assembly's email format?

When was Assembly founded?

Assembly

Company Overview

Media & News

Head to Head Comparison: Parnell Pharmaceuticals (OTCMKTS:PARNF) and Assembly Biosciences (NASDAQ:ASMB)

Financial Survey: Assembly Biosciences (NASDAQ:ASMB) and Sol-Gel Technologies (NASDAQ:SLGL)

Gilead Sciences Exercises Option to License Assembly Biosciences' Helicase-Primase Inhibitor Programs for Recurrent Genital Herpes

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?